Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 12, 2004, Pages

  Liaw, Yun Fan ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Combination therapy; Hepatitis B virus; Monotherapy; Thymalfasin

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; THYMOSIN ALPHA1; ANTIVIRUS AGENT; IMMUNOLOGIC FACTOR; THYMOSIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CELL MATURATION; CHRONIC HEPATITIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HUMAN; IMMUNOMODULATION; META ANALYSIS; MONOTHERAPY; PERINATAL INFECTION; PREVALENCE; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMATIC REVIEW; T LYMPHOCYTE; TH1 CELL; ANALOGS AND DERIVATIVES; DRUG COMBINATION; DRUG EFFECTS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; IMMUNOLOGY; LYMPHOCYTE; VIROLOGY; VIRUS REPLICATION;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOCYTES; THYMOSIN; VIRUS REPLICATION;

EID: 11144234234     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03633.x     Document Type: Conference Paper

References (17)

1. World Health Organization. World Health Organization Fact Sheet no. 204. Hepatitis B. Revised October 2000. [Cited 21 May 2004] Available from URL: http://www.who.International/mediacentre/factsheets/fs204/en/print
2. Liaw YF, Tsai SL. Pathogenesis and clinical significance of acute exacerbations and remissions in patients with chronic hepatitis B virus infection. Viral Hep. Rev. 1997; 3: 143-54.
3. Chisari FV. Viruses, immunity and cancer: lessons from hepatitis B. Am. J. Pathol 2000; 156: 1118-32.
4. Liaw YF, Leung N, Guan R., Lau GKK, Merican I. Asia-Pacific consensus statement on the management of chronic hepatitis B. an update. J. Gastroenterol. Hepatol. 2003; 18: 239-45.
5. Cooksley WG, Piratvisuth T, Lee SD et al. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. J. Viral Hepat. 2003; 10: 298-305.
6. Chien RN, Liaw YN, Chen TC, Yeh CT, Sheen IS. Efficacy of thymosin alpha 1 in patients with chronic hepatitis B: a randomized, controlled trial. Hepatology 1998; 27: 1383-7.
7. Mutchnick MG, Lindsay KL, Schiff ER et al. Thymosin-alpha1 treatment of chronic hepatitis B: results of a Phase III multicentre, randomized, double-blind and placebo-controlled study. J. Viral Hepat. 1999; 6: 397-403.
8. Andreone P, Cursaro C, Gramenzi A et al. A randomized, controlled trial of thymosin-alpha 1 versus interferon-alpha treatment in patients with hepatitis B e antigen antibody and hepatitis B virus DNA-positive chronic hepatitis B. Hepatology 1996; 24: 774-7.
9. Chien RN, Liaw YF. Thymalfasin for the treatment of chronic hepatitis B. Expert Rev. Anti-Infect. Ther. 2004; 2: 9-16.
10. Chan HL, Tang JL, Tam W, Sung JJ. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysys. Alim Pharm. Ther. 2001; 15: 1899-905.
11. Mutchnick MG, Appelman HD, Chung HT et al. Thymosin treatment of chrinic hepatitis B. a placebo-controlled pilot trial. Hepatology 1991; 14: 409-15.
12. You J, Zhuang L, Zhang B et al. A randomized controlled clinical trial on the treatment of thymosin-alpha 1 versus interferon-alfa in patients with hepatitis B. World J. Gastroenterol. 2001; 7: 411-4.
13. Zavaglia C, Severini R, Tinelli C et al. A randomized, controlled study of thymosin-alpha 1 therapy in patients with antiHBe, HBV DNA-positive chronic hepatitis B. Dig. Dis Sci. 2000; 45: 690-6.
14. Zhuang L, You J, Zhang B et al. Preliminary results of thymosin-alpha 1 versus interferon-alfa treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World J. Gastroenterol. 2001; 7: 407-10.
15. Rasi G, Mutchnick MG, Virgilio DD et al. Combination low-dose lymphoblastoid interferon and thymosin-alpha 1 therapy in the treatment of chronic hepatitis B. J. Viral Hepat. 1996; 3: 191-6.
16. Saruc M, Yuceyar H, Kucukmetin N, Demir MA, Kandiloglu AR. Combination thymosin-alpha 1 and interferon alfa-2b in the treatment of antiHBe-positive chronic hepatitis B in Turkey. Hepato-Gastroenterol. 2002; 49: 798-802.
17. Saruc M, Ozden N, Turkel N et al. Long-term outcomes of thymosin-alpha1 and Interferon alfa-2b combination therapy in patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. J. Pharm. Sc. 2003; 92: 1386-95.